CHINA RESOURCES SANJIU MEDICAL & PHARMACEUTICAL CO., LTD. China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. Stock
Equities
000999
CNE0000011K8
Pharmaceuticals
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 63.82 CNY | -1.97% |
|
+0.22% | +28.33% |
| Sales 2024 * | 27.72B 3.83B | Sales 2025 * | 30.98B 4.28B | Capitalization | 64.33B 8.89B |
|---|---|---|---|---|---|
| Net income 2024 * | 3.36B 465M | Net income 2025 * | 3.83B 530M | EV / Sales 2024 * | 2.18 x |
| Net cash position 2024 * | 3.8B 525M | Net cash position 2025 * | 6.15B 849M | EV / Sales 2025 * | 1.88 x |
| P/E ratio 2024 * |
18.7
x | P/E ratio 2025 * |
16.3
x | Employees | 20,318 |
| Yield 2024 * |
2.91% | Yield 2025 * |
3.24% | Free-Float | 36.6% |
More Fundamentals
* Assessed data
More news
| 1 day | -1.97% | ||
| 1 week | +0.22% | ||
| Current month | +4.90% | ||
| 1 month | +4.42% | ||
| 3 months | +16.95% | ||
| 6 months | +28.13% | ||
| Current year | +28.33% |
1 week
63.47
65.84
1 month
59.4165.84
Current year
48.1265.84
1 year
40.5265.84
3 years
23.3468.96
5 years
23.3468.96
10 years
17.9968.96
| Managers | Title | Age | Since |
|---|---|---|---|
Hua Wei Qiu
CEO | Chief Executive Officer | 57 | 07-12-26 |
Zheng Liang
DFI | Director of Finance/CFO | 46 | 19-10-28 |
Ji Hong Zhang
CMP | Compliance Officer | 53 | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Fang Xu
BRD | Director/Board Member | 61 | 18-04-22 |
Hua Wei Qiu
CEO | Chief Executive Officer | 57 | 07-12-26 |
Ying Tan
PRN | Corporate Officer/Principal | 61 | 05-12-31 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.83% | 1 M€ | -17.17% | - | |
| 0.69% | 2 M€ | -14.14% |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-06-11 | 63.82 | -1.97% | 5 386 500 |
| 24-06-11 | 65.1 | +0.70% | 5,610,825 |
| 24-06-07 | 64.65 | +0.02% | 4,555,544 |
| 24-06-06 | 64.64 | +1.16% | 5,362,318 |
| 24-06-05 | 63.9 | +0.35% | 5,150,659 |
End-of-day quote Shenzhen S.E., June 11, 2024
More quotes
China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. specializes in the development, manufacturing and marketing of pharmaceutical products. The group proposes primarily prescribed drugs, OTC drugs and generic drugs.
Sector
Pharmaceuticals
Calendar
2024-08-21
- Q2 2024 Earnings Release (Projected)
Trading Rating
Investor Rating
ESG Refinitiv
B-
Sell
Buy
Mean consensus
BUY
Number of Analysts
13
Last Close Price
63.82
CNY
Average target price
71.73
CNY
Spread / Average Target
+12.40%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +28.33% | 8.88B | |
| +49.05% | 780B | |
| +41.76% | 627B | |
| +20.15% | 334B | |
| +7.06% | 296B | |
| +17.60% | 244B | |
| -0.41% | 217B | |
| +11.54% | 214B | |
| +4.28% | 161B | |
| -3.53% | 159B |
- Stock Market
- Equities
- 000999 Stock
